IFN (IFN) Stock Price & Analysis
IFN (IFN) rose 0.97% to USD 11.43 as of July 25, 2026 at 08:27 UTC, according to Nexqual real-time market data.
IFN last closed at USD 11.32; the session ranged USD 11.35–11.47 on volume of 89,571 shares. Market capitalization is $487.51M, with a 52-week range of USD 10.72–15.95 (NYQ). Source: Nexqual, July 25, 2026 at 08:27 UTC.
Key Statistics (as of July 25, 2026 at 08:27 UTC)
| Price | USD 11.43 |
|---|---|
| Change | ▲ 0.97% (up) |
| Previous Close | USD 11.32 |
| Open | USD 11.35 |
| Day Range | USD 11.35 – 11.47 |
| 52-Week Range | USD 10.72 – 15.95 |
| Volume | 89,571 shares |
| Market Cap | $487.51M |
| Exchange | NYQ |
Technical Analysis (IFN)
Nexqual's technical model rates IFN "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 08:27 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 55.16 (neutral) |
| vs SMA50 | Above (USD 11.38) |
| MACD | -0.02 (negative) |
Analyst Ratings (IFN)
Wall Street analysts rate IFN "None", per Nexqual as of July 25, 2026 at 08:27 UTC.
| Consensus Rating | None |
|---|
Earnings (IFN)
Source: Nexqual, July 25, 2026 at 08:27 UTC.
Financials & Fundamentals (IFN)
| Total Revenue | $5.23M |
|---|---|
| Revenue Growth (YoY) | -16.00% |
| Gross Margin | +100.00% |
| Operating Margin | -103.29% |
| Profit Margin | +0.00% |
| ROE | -6.95% |
| Current Ratio | 0.44 |
| Total Cash | $9.91M |
| Total Debt | $0 |
Source: Nexqual, July 25, 2026 at 08:27 UTC.
Financial Health Score (IFN)
Nexqual rates IFN's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 08:27 UTC.
| Growth | Critical — Revenue -16% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $10M cash, no debt |
| Cash Flow | Mixed — No data |
| Efficiency | Critical — ROE -7%, ROA -0.3% |
Ownership (IFN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +14.42% |
| Shares Outstanding | 42.65M |
| Short % of Float | +0.70% |
Source: Nexqual, July 25, 2026 at 08:27 UTC.
Leadership (IFN)
IFN is led by Gary Robert Marshall (age 64), Vice President, per Nexqual as of July 25, 2026 at 08:27 UTC.
| Vice President | Gary Robert Marshall (age 64) |
|---|
Major Backers & Investors (IFN)
Notable institutional backers of IFN include Morgan Stanley, Penserra Capital Management LLC, Amplify ETF Trust-Amplify CEF High Income ETF, according to Nexqual as of July 25, 2026 at 08:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 2.92% |
| Penserra Capital Management LLC | 2.61% |
| Amplify ETF Trust-Amplify CEF High Income ETF | 2.6% |
| Cetera Investment Advisers | 1.46% |
| City of London Investment Management Co. Limited | 1.36% |
| Raymond James Financial, Inc. | 0.68% |
| LPL Financial LLC | 0.63% |
| UBS Group AG | 0.58% |
Source: Nexqual, July 25, 2026 at 08:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IIF | Morgan Stanley India Investment | USD 22.29 | ▼ 0.09% |
| IBN | ICICI Bank Limited | USD 29.51 | ▲ 0.2% |
| CEE | The Central and Eastern Europe | USD 20.74 | ▲ 0.63% |
| KF | Korea Fund, Inc. (The) New | USD 59.44 | ▼ 4.61% |
| RDY | Dr. Reddy's Laboratories Ltd | USD 11.79 | ▲ 3.6% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 08:27 UTC. This page is informational and not investment advice.